
Opinion|Videos|December 25, 2024
Exploring Second-Line Treatments for PBC
Panelists discuss how some patients with primary biliary cholangitis (PBC) have an inadequate response to ursodeoxycholic acid and require second-line treatments, with options including obeticholic acid, seladelpar, and elafibranor, which improve bile acid homeostasis and reduce inflammation.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How often do patients require second-line treatments for PBC, and what agents are available for second-line management?
- How do the mechanisms of action differ between seladelpar, elafibranor, and obeticholic acid?
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists as the Glue in Cardio-Kidney-Metabolic Care
2
Pharmacists Can Close the LDL Control Gap in Lipid Care
3
Extended-Interval Tarlatamab Dosing Offers Pharmacists More Flexible Administration Windows in SCLC
4
Cancer Among 9/11 Survivors Is Accelerating 25 Years Later
5































































































